Literature DB >> 3756867

Disposition of homocysteine in rat hepatocytes and in nontransformed and malignant mouse embryo fibroblasts following exposure to inhibitors of S-adenosylhomocysteine catabolism.

A M Svardal, R Djurhuus, H Refsum, P M Ueland.   

Abstract

S-Adenosylhomocysteine (AdoHcy) is catabolized to adenosine and homocysteine through the action of AdoHcy hydrolase, and this reaction is the only known source of L-homocysteine in vertebrates. The disposition of endogenously formed L-homocysteine was investigated in isolated rat hepatocytes and nontransformed and malignant C3H/10T1/2 mouse embryo fibroblasts exposed to 3-deazaaristeromycin or D-eritadenine, compounds which are potent inhibitors of AdoHcy hydrolase. Cells in suspension release large amounts of L-homocysteine into the extracellular medium whereas small amounts are retained within the intracellular compartment. The L-homocysteine egress is inhibited by 3-deazaaristeromycin or D-eritadenine in a manner which closely parallels the inhibitory effect on AdoHcy catabolism, suggesting that L-homocysteine egress may be coupled to its formation from AdoHcy. In liver cells, the accumulation of AdoHcy exceeded the inhibition of L-homocysteine egress, whereas in the fibroblasts inhibition of egress equalled the accumulation of AdoHcy. Inhibition of AdoHcy catabolism was associated with an increase in both free and protein bound L-homocysteine in liver cells, whereas depletion of intracellular L-homocysteine occurred in the mouse embryo fibroblasts under these conditions. These data suggest that some properties of nucleoside analogues may be related to their effects on L-homocysteine metabolism. Furthermore, L-homocysteine is exported into the extracellular medium in proportion to the formation from AdoHcy, and extracellular L-homocysteine may be a measure of the balance between L-homocysteine formation and utilization.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3756867

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  1 in total

1.  Hyperhomocysteinemia and the response to vitamin supplementation.

Authors:  J B Ubbink; A van der Merwe; W J Vermaak; R Delport
Journal:  Clin Investig       Date:  1993-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.